From our CEO
22 May 2024
CEO Rohan Greenland outlines the good points and the missed opportunities from the recent federal budget and looks ahead to the agenda of the national summit on neurological conditions.
CEO Rohan Greenland outlines the good points and the missed opportunities from the recent federal budget and looks ahead to the agenda of the national summit on neurological conditions.
The 2024-25 Federal Budget, delivered on 14 May 2024, addresses several critical needs for the MS community, focusing on better treatments, prevention, and support.
Antibodies detected years before MS diagnosis may help identify people at high risk of developing MS
20 May marks Clinical Trials Day, a day dedicated to recognising the importance of clinical trials in medical research and healthcare advancement.
Hannah had been grappling with a series of symptoms for years before her MS diagnosis
My first symptoms of MS began in April 1995. I was 35 years old with three young children at school, doing my dream job in the Police Force and training for a triathlon.
MS Australia has welcomed the Government’s pledge to invest in health and medical research but is concerned that not enough attention or funding is being dedicated to neurological research.
New study reveals early highly effective therapy significantly reduces disability progression in paediatric MS, offering hope for preserving neurological function.
The Big MS Data network consists of multiple national and international MS registries offering significant advantages for real-world data analysis.